Nursing care
Medication Administration Routes, explained for the bedside and the exam
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
A medication administration route is the path by which a drug enters the body, such as oral, IV, IM, subcutaneous, or topical, and route changes both how fast a drug works and what dose is needed. An oral dose given IV is not the same drug at the same strength; bioavailability differs by route, so doses are not interchangeable without a prescriber's adjustment.
What the concept actually says
Every drug order specifies a route because the route determines how much of the drug actually reaches the bloodstream and how quickly. Oral medications pass through the gut and liver before reaching circulation, a process called first-pass metabolism, which reduces the amount of active drug available. IV medications bypass this entirely and enter circulation at full concentration immediately, which is why IV doses of many drugs are lower than oral doses of the same drug.
This is not a minor technicality. Morphine given orally requires a substantially higher dose than morphine given IV to achieve the same effect, because oral bioavailability is a fraction of IV bioavailability. A nurse who treats route as interchangeable with dose held constant is not administering the same drug at a different speed; they are administering a different exposure altogether.
The clinical reasoning behind it
Route selection reflects three things: how fast the effect is needed, what the patient's body can absorb, and what the drug itself can tolerate. A patient in anaphylaxis needs epinephrine IM or IV because oral absorption is too slow and too unreliable when perfusion is compromised. A patient who cannot swallow safely needs an alternative to oral dosing regardless of how well the oral form usually works, because the problem is delivery, not the drug.
Some drugs are destroyed by stomach acid or gut enzymes and simply cannot be given orally at all, insulin being the clearest example. Others are too irritating to tissue for IM or subcutaneous use and must go IV. Route, in other words, is chosen against the constraints of the drug's chemistry and the patient's physiology, not out of habit or convenience. When a prescriber writes a route, they have already made that judgment; a nurse changing the route without a new order is making a clinical decision they are not authorised to make alone.
Applying it under time pressure
In an urgent situation, the instinct is to give the fastest-acting route available, but fastest is not always correct. IV access takes time to establish in a hypovolemic or paediatric patient, and IM or intranasal routes exist precisely because they are faster to access even if slightly slower to act, as with intranasal naloxone or IM glucagon.
Before switching a route in an emergency, confirm whether an order exists for that route or whether it falls under a standing protocol. If a patient's oral medication is due but they are now NPO or unconscious, do not give it via a feeding tube or IV without checking whether the drug is even formulated for that route; crushing an extended-release tablet, for instance, destroys the mechanism that made the release extended and can deliver the full dose at once.
Common misconceptions
The most persistent error is assuming a dose is fixed and only the route flexes around it. In reality, many drugs have route-specific dosing precisely because bioavailability differs, and an order written for one route cannot simply be given by another route at the same number of milligrams without prescriber input.
A second misconception is that subcutaneous and intramuscular injections are interchangeable because both use a needle. They differ in absorption rate, needle length, and site selection, and giving a drug meant for deep muscle into subcutaneous tissue, or vice versa, changes how quickly and how completely it is absorbed. A third misconception is that topical means local only; some topical and transdermal drugs are designed for systemic absorption and carry systemic risks, such as opioid patches.
Practice scenarios
A patient's oral antihypertensive is due but they have been made NPO for a morning procedure. The correct response is to hold the dose and notify the prescriber, not to substitute a route on your own judgment, since no equivalent IV order exists without one being written.
A patient prescribed enoxaparin subcutaneously is found to have it charted as an IM injection by a covering nurse. The nurse recognising the error should intervene before administration, since enoxaparin given IM carries a bleeding and hematoma risk that subcutaneous administration into the correct tissue layer avoids. A postoperative patient with poor peripheral access needs pain control, and the order includes both oral and IV formulations of the same drug; the nurse should assess swallowing ability and gut function, not assume oral is always safer just because it is less invasive.
Key takeaways
Route is not a delivery preference layered on top of a fixed dose; it is part of what determines the dose. Always administer the route that is ordered, and treat any need to change it as a prescriber decision, not a bedside judgment call, except where an approved protocol explicitly authorises the change.
When in doubt about whether a drug can be given by an alternate route, or whether a formulation can be crushed, split, or given via tube, check a current drug reference rather than relying on habit from a similar-looking drug. Route errors are dosing errors even when the correct number of milligrams is drawn up.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Why is the IV dose of a drug often lower than the oral dose?
Oral drugs pass through the liver before reaching circulation, a process called first-pass metabolism, which breaks down a portion of the dose before it becomes active. IV drugs bypass this step and enter circulation at full strength, so a smaller IV dose can produce the same effect as a larger oral dose.
Can a nurse change a medication's route without a new order?
No, not outside of an approved standing protocol. Route is a specific part of the prescriber's order because it affects dose and safety, so changing it requires prescriber input, even if the change seems minor or the patient's situation seems to demand it urgently.
Is it safe to crush an extended-release tablet to give via feeding tube?
No. Crushing an extended-release or enteric-coated tablet destroys the mechanism that controls its release, which can deliver the entire dose at once and cause toxicity. Check a drug reference or pharmacy for a liquid or alternate formulation instead.
What is the difference in absorption between IM and subcutaneous injections?
Muscle tissue has a richer blood supply than subcutaneous fat, so IM injections are absorbed faster than subcutaneous ones. This is why some drugs, like certain vaccines or insulin, specify one route over the other, and giving a drug into the wrong tissue layer changes how quickly it takes effect.
Why can't insulin be given orally?
Insulin is a protein, and digestive enzymes in the stomach and intestine break it down before it can be absorbed intact. This is a chemistry limitation of the drug itself, not a dosing preference, which is why insulin is given by injection or, in newer formulations, by other non-oral routes designed to avoid gut breakdown.
More on pharmacology
Guides on this